What is Regenxbio's PP&E (net)?

Regenxbio (RGNX) reported PP&E (net) of $101.87M in Q1 2026.

How has Regenxbio's PP&E (net) changed year-over-year?

Regenxbio's PP&E (net) decreased by 11.0% year-over-year, from $114.5M to $101.87M.

What is the long-term trend for Regenxbio's PP&E (net)?

Over 5 years (2020 to 2025), Regenxbio's PP&E (net) has grown at a 13.2% compound annual growth rate (CAGR), from $56.47M to $104.86M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Regenxbio RGNX PP&E (Net)

PP&E (Net) at other companies

Sarepta Therapeutics, Inc.SRPT

$336.24M-6.8%

BiogenBIIB

$3.02B-3.7%

BioMarin PharmaceuticalsBMRN

$958.07M-7.2%

EyePoint, Inc. EYPT

$9.48M+17.9%

Ultragenyx PharmaceuticalRARE

$239M-8.4%

4D Molecular TherapeuticsFDMT

$13.59M-27.5%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's PP&E (net)?: Regenxbio (RGNX) reported PP&E (net) of $101.87M in Q1 2026.
How has Regenxbio's PP&E (net) changed year-over-year?: Regenxbio's PP&E (net) decreased by 11.0% year-over-year, from $114.5M to $101.87M.
What is the long-term trend for Regenxbio's PP&E (net)?: Over 5 years (2020 to 2025), Regenxbio's PP&E (net) has grown at a 13.2% compound annual growth rate (CAGR), from $56.47M to $104.86M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.